Home » Newsletters » BioWorld

BioWorld

Feb. 11, 1992

View Archived Issues

G-CSF Preferable in Some Cases

Regenerons CNTF Designated Orphan Drug

MEDICORP ACQUIRES TECHNOLOGY RIGHTS

FDA APPROVES ONCOR CANCER DIAGNOSTIC

INJECTABLE SMOKING DRUG ENTERS PHASE II

IPIC TO COLLABORATE WITH OHIO STATE

PROCYTE DISCUSSES WOUND-HEALING COMPOUND

ALPHA 1 TAKES $1 MILLION ORDER

STERLING WINTHROP LICENSES BIOMIRA MAbs

MGI HALTS CHEMOPROTECTIVE TRIALS